$46.69
+1.88 (+4.20%)
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+6.7% upside
Low Target
$29.15
Average Target
$49.81
High Target
$64.16
Current Price
$46.69
Current
$46.69
$46.69
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Scenario Analysis
Bear Case
$29.15
-37.6%
Low target
Base Case
$49.81
+6.7%
Avg target
Bull Case
$64.16
+37.4%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$49.76
-6.2% from high
52-Week Low
$11.26
+314.7% from low
Target vs 52W High
$49.81
+0.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |